Phase 3 Pertussis Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 2Phase 3
A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series
DiphtheriaPoliomyelitisHepatitis B+3 more
LG Chem1,186 enrolled1 locationNCT06947499
Recruiting
Phase 3
Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV
Diptheria ImmunizationTetanus ImmunizationPertussis Immunization+3 more
Serum Institute of India Pvt. Ltd.1,557 enrolled9 locationsNCT06413121
Completed
Phase 2Phase 3
Pertaprime: A study to assess the immune response and safety of a new pertussis vaccine (Pertagen®) in healthy young adults.
Pertussis prevention
Telethon Kids Institute102 enrolled1 locationACTRN12619000944134
Completed
Phase 3
Follow up of immunogenicity and safety of acellular pertussis vaccine given at birth to 4 years of age
Pertussis immunogenicity
The Sydney Children's Hospitals Network200 enrolled4 locationsACTRN12614001325695
Recruiting
Phase 3Phase 4
Does early whooping cough (pertussis) vaccination provide earlier antibody protection for infants?
Pertussis infection
National Centre for Immunisation Research and Surveillance80 enrolled1 locationACTRN12605000013662